12 March 2020

Ceva returns to strong double-digit growth in 2019 and reveals plans to double sales by 2025 >

Libourne, 12 March 2020 - Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019 as the company returned to strong double-digit growth (+14.6%). The start of 2020 was marked by the renewal of its shareholding structure with new long-term partners investing alongside management and historic minority investors with the aim of ensuring the continued independent development of the...

28 February 2020

Honoring biodiversity this year in the Grand-Est, Normandy and Centre-Val-de-Loire regions >

Paris, March 2, 2020 - For the 8th consecutive year, the "Fondation du Patrimoine National Animal Agrobiodiversity Prize" has been awarded on the occasion of the International Agricultural Show. Two breeders and one association received awards for their commitment to the preservation and promotion of endangered French agricultural breeds.

4 February 2020

Ceva reorganizes its shareholding structure welcoming new long-term partners alongside existing investors to secure the group’s independent future. >

Libourne, 4 February 2020: Ceva Santé Animale today announced that it has renewed its shareholding structure, welcoming leading international investors to join long-term partners, who will invest alongside management to secure the continued independent development of the group.

16 January 2020

Ceva commits to helping improve preventative health strategies for Vietnam’s rapidly growing livestock sector >

Hanoi, Vietnam, 16 January 2020 - Ceva Santé Animale signed several agreements with the Vietnam Department of Animal Health (DAH) to accelerate the implementation of preventive health strategies, including the research and development of new vaccines for Vietnamese livestock sector.

1 October 2019

ProBioGen and Ceva Santé Animale sign an exclusive license agreement to produce vectorised poultry vaccines using AGE1.CR® production technology >

Berlin, Germany and Libourne, France 01st October 2019 - ProBioGen AG and Ceva Santé Animale announce the signature of an exclusive license agreement for the manufacture of vectorised poultry vaccines using ProBioGen’s proprietary AGE1.CR® technology.

18 September 2019

Ceva brings together international experts in human cardiology and veterinary to stimulate innovation >

Cardio Symposium Human - Veterinary 2019 (September 17 - Milan)

10 September 2019

Ceva partners with Biotecon Diagnostics to introduce a real-time test kit to fight growing problem of salmonella on pig farms >

Libourne 10th September 2019 - A new real-time diagnostic kit that will help pig producers fight salmonella infections on their farms has been launched at the SafePork scientific symposium in Berlin.

9 September 2019

World Veterinary Association and Ceva Santé Animale enlarge the scope of the Global Animal Welfare Awards by adding new award categories >

Ceva Santé Animale (Ceva) and the World Veterinary Association (WVA) enlarge the scope of the Global Animal Welfare Awards to recognize veterinary technicians/nurses and veterinary schools in addition to veterinarians and veterinary students for their exemplary work in protecting and promoting Animal Welfare.

10 July 2019

Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries >

Libourne 8th July 2019 - Pig farmers in 12 European countries will now be able to protect their herds against the growing problem of Salmonella Typhimurium. Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.

3 July 2019

Ceva completes acquisition of IDT veterinary business assets, moving closer to its 2020 objective of 50:50 bio-pharma split >

Libourne & Dessau 3rd July 2019 - Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) today announced that they have successfully completed the acquisition of IDT’s veterinary biopharmaceutical and R&D activities by Ceva. The product portfolio will be transferred to Ceva branding as quickly as possible. A new Global innovation center focused on swine vaccines will be created within IDT’s exiting...